{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:20:10Z","timestamp":1790734810115,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.diabres.2026.113172","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:16:14Z","timestamp":1771658174000},"page":"113172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Hyperglycaemia-induced metabolic stress and epigenetic imprinting in the inflammatory pathogenesis of diabetic neuropathy"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7410-555X","authenticated-orcid":false,"given":"Faaz Bin","family":"Razi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziaul","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shagufta","family":"Moin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"760","key":"10.1016\/j.diabres.2026.113172_b0005","article-title":"Epigenetic regulation of Nrf2-Mediated angiogenesis in diabetic foot ulcer progression: Role of histone deacetylases","volume":"1","author":"Harithpriya","year":"2024","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/ijms21030881","article-title":"High-mobility group box 1 protein signaling in painful diabetic neuropathy","volume":"21","author":"Thakur","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.diabres.2026.113172_b0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/cells12020300","article-title":"Cross talks between oxidative stress, inflammation and epigenetics in diabetic retinopathy","volume":"12","author":"Kowluru","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","article-title":"An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory","volume":"30","author":"Yang","year":"2024","journal-title":"Mol Med"},{"issue":"154","key":"10.1016\/j.diabres.2026.113172_b0025","article-title":"Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects","volume":"1","author":"He","year":"2024","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14703","article-title":"SIRT3 alleviates painful diabetic neuropathy by mediating the FoxO3a\u2010PINK1\u2010Parkin signaling pathway to activate mitophagy","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.diabres.2026.113172_b0035","article-title":"Mitochondrial dysfunction in diabetic neuropathy: Impaired mitophagy triggers NLRP3 inflammasome","volume":"2","author":"Sriwastawa","year":"2024","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/biomedicines13030589","article-title":"Cytokine signaling in diabetic neuropathy: a key player in peripheral nerve damage","volume":"13","author":"Nashtahosseini","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0050","article-title":"The role of oxidative stress, mitochondrial function, and autophagy in diabetic polyneuropathy","volume":"2017","author":"Sifuentes-Franco","year":"2017","journal-title":"Journal of diabetes research"},{"issue":"359","key":"10.1016\/j.diabres.2026.113172_b0055","article-title":"Bay 11-7082 mitigates oxidative stress and mitochondrial dysfunction via NLRP3 inhibition in experimental diabetic neuropathy","volume":"15","author":"Sharan","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2026.113172_b0060","first-page":"1","article-title":"Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy","volume":"9","author":"Khanna","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/j.diabres.2026.113172_b0065","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41419-021-03930-2","article-title":"TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0070","article-title":"Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets","volume":"2014","author":"Sandireddy","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113172_b0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-\u03ba\u03b2: a potential target in the management of vascular complications of diabetes","volume":"7","author":"Suryavanshi","year":"2017","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.diabres.2026.113172_b0080","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biochi.2012.01.023","article-title":"Suppression of NF-\u03baB and NF-\u03baB regulated oxidative stress and neuroinflammation by BAY 11-7082 (I\u03baB phosphorylation inhibitor) in experimental diabetic neuropathy","volume":"94","author":"Kumar","year":"2012","journal-title":"Biochimie"},{"issue":"144","key":"10.1016\/j.diabres.2026.113172_b0085","article-title":"Inhibition of S100A8\/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy","volume":"1","author":"Du","year":"2023","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13578-020-00388-1","article-title":"P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes","volume":"10","author":"Wang","year":"2020","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s43556-025-00305-3","article-title":"Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy","volume":"6","author":"Lin","year":"2025","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.diabres.2026.113172_b0100","article-title":"DAMP signaling networks: from receptors to diverse pathophysiological functions","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"issue":"371","key":"10.1016\/j.diabres.2026.113172_b0105","article-title":"The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation","volume":"15","author":"Serna-Rodr\u00edguez","year":"2022","journal-title":"J Neuroimmunol"},{"issue":"264","key":"10.1016\/j.diabres.2026.113172_b0110","article-title":"Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis","volume":"15","author":"Yu","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.diabres.2026.113172_b0115","doi-asserted-by":"crossref","unstructured":"Bestall SM, Hulse RP, Blackley Z, Swift M, Ved N, Paton K, Beazley-Long N, Bates DO, Donaldson LF. Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions. Journal of cell science. 2018 Jul 15;131(14):jcs215939.","DOI":"10.1242\/jcs.215939"},{"issue":"6","key":"10.1016\/j.diabres.2026.113172_b0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.35975\/apic.v27i6.2338","article-title":"Potential role of S100A8\/A9 and RNA-binding protein in microvascular complications of type2 diabetes mellitus","volume":"27","author":"Sarhan","year":"2023","journal-title":"Anaesthesia, Pain & Intensive Care"},{"issue":"10","key":"10.1016\/j.diabres.2026.113172_b0125","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3389\/fphys.2019.01557","article-title":"Mitochondrial DNA promotes NLRP3 inflammasome activation and contributes to endothelial dysfunction and inflammation in type 1 diabetes","volume":"17","author":"Pereira","year":"2020","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.diabres.2026.113172_b0130","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1101\/gr.280155.124","article-title":"Epigenetic drift score captures directional methylation variability and links aging to transcriptional, metabolic, and genetic alterations","volume":"35","author":"Fan","year":"2025","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.diabres.2026.113172_b0135","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","article-title":"Metabolic memory: mechanisms and diseases","volume":"9","author":"Dong","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.diabres.2026.113172_b0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrendo.2010.188","article-title":"Epigenetic phenomena linked to diabetic complications","volume":"6","author":"Pirola","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113172_b0150","article-title":"NRF2-related epigenetic modifications in cardiac and vascular complications of diabetes mellitus","volume":"25","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0155","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.diabres.2026.113172_b0160","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2337\/db12-1648","article-title":"SIRT1, p66Shc, and Set7\/9 in vascular hyperglycemic memory: bringing all the strands together","volume":"62","author":"Paneni","year":"2013","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.diabres.2026.113172_b0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.diabres.2026.113172_b0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.305510","article-title":"lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA","volume":"116","author":"Yan","year":"2015","journal-title":"Circ Res"},{"issue":"21","key":"10.1016\/j.diabres.2026.113172_b0175","doi-asserted-by":"crossref","first-page":"E3002","DOI":"10.1073\/pnas.1603712113","article-title":"Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT\/EDIC type 1 diabetes cohort","volume":"113","author":"Chen","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.diabres.2026.113172_b0180","doi-asserted-by":"crossref","unstructured":"Wegner M, Neddermann D, Piorunska-Stolzmann M, Jagodzinski PP. Role of epigenetic mechanisms in the development of chronic complications of diabetes. Diabetes research and clinical practice. 2014 Aug 1;105(2):164-75.","DOI":"10.1016\/j.diabres.2014.03.019"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.diabres.2026.113172_b0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"Kato","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2026.113172_b0195","first-page":"1","article-title":"DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study","volume":"23","author":"Zhou","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113172_b0200","doi-asserted-by":"crossref","unstructured":"Zhou J, Mychaleckyj J, Onengut-Gumuscu S, Orchard TJ, Costacou T, Miller RG. 1461-P: DNA Methylation (DNAm) and 28-Year Risk of Diabetic Peripheral Neuropathy (DPN) in Type 1 Diabetes (T1D) The Epidemiology of Diabetes Complications (EDC) Study. Diabetes. 2024 Jun 14;73(Supplement_1):1461-P.","DOI":"10.2337\/db24-1461-P"},{"issue":"12","key":"10.1016\/j.diabres.2026.113172_b0205","article-title":"Epigenetics and beyond: targeting histone methylation to treat type 2 diabetes mellitus","volume":"11","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0210","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/genes13040705","article-title":"The role of epigenetic modifications in late complications in type 1 diabetes","volume":"13","author":"\u010cugalj Kern","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13148-023-01539-0","article-title":"DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study","volume":"15","author":"Miller","year":"2023","journal-title":"Clin Epigenetics"},{"issue":"9","key":"10.1016\/j.diabres.2026.113172_b0220","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3390\/ijms22094887","article-title":"Genetic and epigenomic modifiers of diabetic neuropathy","volume":"22","author":"Jankovic","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11892-010-0120-8","article-title":"DCCT\/EDIC Research Group. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history","volume":"10","author":"Pop-Busui","year":"2010","journal-title":"Curr Diab Rep"},{"issue":"2\u20133","key":"10.1016\/j.diabres.2026.113172_b0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.brainresbull.2009.05.006","article-title":"Metabolic memory in diabetes-from in vitro oddity to in vivo problem: Role of Apoptosis","volume":"81","author":"Kowluru","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.diabres.2026.113172_b0235","doi-asserted-by":"crossref","unstructured":"Alhazzaa RA, Heinbockel T, Csoka AB. Diabetes and epigenetics. Epigenetics to Optogenetics-a New Paradigm in the Study of Biology. 2022 May 5.","DOI":"10.5772\/intechopen.104653"},{"issue":"2","key":"10.1016\/j.diabres.2026.113172_b0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1086\/675979","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series)","volume":"4","author":"Loscalzo","year":"2014","journal-title":"Pulmonary circulation"},{"issue":"13","key":"10.1016\/j.diabres.2026.113172_b0245","article-title":"Inflammation-related epigenetic modification: the bridge between immune and metabolism in type 2 diabetes","volume":"6","author":"Ding","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/cvr\/cvr024","article-title":"Epigenetic mechanisms in diabetic vascular complications","volume":"90","author":"Reddy","year":"2011","journal-title":"Cardiovascular research"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0255","article-title":"Epigenetic regulations in diabetic nephropathy","volume":"2017","author":"Lu","year":"2017","journal-title":"Journal of diabetes research"},{"key":"10.1016\/j.diabres.2026.113172_b0260","doi-asserted-by":"crossref","unstructured":"Bestall SM, Hulse RP, Blackley Z, Swift M, Ved N, Paton K, Beazley-Long N, Bates DO, Donaldson LF. Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions. Journal of cell science. 2018 Jul 15;131(14):jcs215939.","DOI":"10.1242\/jcs.215939"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s10020-024-00939-z","article-title":"Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapies","volume":"30","author":"Damiano","year":"2024","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0270","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabres.2026.113172_b0275","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2147\/DMSO.S479077","article-title":"Targeting the epigenetic marks in type 2 diabetes mellitus: will epigenetic therapy be a valuable adjunct to pharmacotherapy?","volume":"31","author":"Odimegwu","year":"2024","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"issue":"15","key":"10.1016\/j.diabres.2026.113172_b0280","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.3390\/ijms25158324","article-title":"Epigenetic landscapes of pain: DNA methylation dynamics in chronic pain","volume":"25","author":"Xiong","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0285","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s12035-023-03701-4","article-title":"Role of histone deacetylase inhibitor in diabetic painful neuropathy","volume":"61","author":"Thakur","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"13","key":"10.1016\/j.diabres.2026.113172_b0290","article-title":"Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases","volume":"16","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5493\/wjem.v8.i3.18","article-title":"Circulating microRNAs as biomarkers for diabetic neuropathy: a novel approach","volume":"8","author":"Xourgia","year":"2018","journal-title":"World journal of experimental medicine"},{"issue":"11","key":"10.1016\/j.diabres.2026.113172_b0300","article-title":"Emerging roles of microRNAs as biomarkers and therapeutic targets for diabetic neuropathy","volume":"22","author":"Fan","year":"2020","journal-title":"Front Neurol"},{"issue":"163","key":"10.1016\/j.diabres.2026.113172_b0305","article-title":"Blockade of receptor for advanced glycation end-products with azeliragon ameliorates streptozotocin-induced diabetic neuropathy","volume":"1","author":"Ma","year":"2023","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/db12-0632","article-title":"RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice","volume":"62","author":"Juranek","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2026.113172_b0315","first-page":"371","article-title":"The role of inflammation in the pathogenesis of diabetic peripheral neuropathy: new lessons from experimental studies and clinical implications","volume":"16","author":"Panou","year":"2025","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.diabres.2026.113172_b0320","unstructured":"Tidswell MD M. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: The ACCESS randomized trial."},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-020-2097-2","article-title":"Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug","volume":"22","author":"Samarpita","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.diabres.2026.113172_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2025.10.052","article-title":"TLR4 deletion reduces small fiber sensory abnormalities and nerve degeneration in diabetic male mice","author":"Crowards","year":"2025","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.diabres.2026.113172_b0335","article-title":"Sodium-glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway","volume":"6","author":"Zhan","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"102","key":"10.1016\/j.diabres.2026.113172_b0340","article-title":"Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy","volume":"1","author":"Aghamiri","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"158","key":"10.1016\/j.diabres.2026.113172_b0345","article-title":"New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies","volume":"1","author":"Zou","year":"2024","journal-title":"Metabolism"},{"issue":"16","key":"10.1016\/j.diabres.2026.113172_b0350","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.3390\/molecules26164996","article-title":"Promise of the NLRP3 inflammasome inhibitors in in vivo disease models","volume":"26","author":"Das","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.diabres.2026.113172_b0355","doi-asserted-by":"crossref","unstructured":"Borowiec AM, W\u0142aszczuk A, Olakowska E, Lewin-Kowalik J. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Medicine and pharmacy reports. 2022 Jul 26;95(3):243.","DOI":"10.15386\/mpr-2187"},{"key":"10.1016\/j.diabres.2026.113172_b0360","doi-asserted-by":"crossref","unstructured":"Faaz Bin Razi, Perveen Akhter, Aparaajita Bhatnaagar, Sheema Wazib, Vineet Jain and Iqbal Alam (2025). Effects of Triticum aestivum L. supplementation on lipid profiles and oxidative stress markers in overweight and obese individuals. Ann. Phytomed., 14(1):728-735. http:\/\/dx.doi.org\/10.54085\/ap.2025.14.1.71.","DOI":"10.54085\/ap.2025.14.1.71"},{"key":"10.1016\/j.diabres.2026.113172_b0365","article-title":"Neuroinflammation and metabolic dysfunction drive nerve conduction deficits in diabetic neuropathy: Clinical and in silico insights","volume":"26","author":"Razi","year":"2025","journal-title":"J Neuroimmunol"},{"issue":"170","key":"10.1016\/j.diabres.2026.113172_b0370","article-title":"Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives","volume":"1","author":"Islam","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s43042-024-00595-2","article-title":"Mechanism of metabolic memory: progression in diabetic nephropathy a descriptive review","volume":"25","author":"Begum","year":"2024","journal-title":"Egyptian Journal of Medical Human Genetics"},{"issue":"1","key":"10.1016\/j.diabres.2026.113172_b0380","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/CM9.0000000000003230","article-title":"Oxidative stress in diabetes mellitus and its complications: from pathophysiology to therapeutic strategies","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.diabres.2026.113172_b0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ph14020077","article-title":"Peripheral mechanisms of neuropathic pain\u2014the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain","volume":"14","author":"Kocot-K\u0119pska","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.diabres.2026.113172_b0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-33437-1","article-title":"Bromodomain and extra-terminal protein inhibitors modulate natural killer cell function and differentiation","author":"Geanes","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113172_b0395","doi-asserted-by":"crossref","unstructured":"Barbalho SM, Leme Boaro B, da Silva Camarinha Oliveira J, Pato\u010dka J, Barbalho Lamas C, Tanaka M, Laurindo LF. Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature. Pharmaceuticals. 2025 Jan 20;18(1):133.","DOI":"10.3390\/ph18010133"},{"key":"10.1016\/j.diabres.2026.113172_b0400","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016(1):9259646","author":"Rider","year":"2016","journal-title":"International journal of cell biology"},{"issue":"9","key":"10.1016\/j.diabres.2026.113172_b0405","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70369","article-title":"Epigenetic Regulation of Aging and its Rejuvenation","volume":"6","author":"An","year":"2025","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.diabres.2026.113172_b0410","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/15592294.2019.1615352","article-title":"Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus","volume":"14","author":"Guo","year":"2019","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0415","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2337\/db24-0930","article-title":"High-resolution whole-genome DNA methylation revealed unique signatures of painful diabetic neuropathy","volume":"74","author":"Kwiatkowska","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113172_b0420","doi-asserted-by":"crossref","unstructured":"2002: Thakur V, Gonzalez MA, Parada M, Martinez RD, Chattopadhyay M. Role of histone deacetylase inhibitor in diabetic painful neuropathy. Molecular Neurobiology. 2024 Apr;61(4):2283-96.","DOI":"10.1007\/s12035-023-03701-4"},{"key":"10.1016\/j.diabres.2026.113172_b0425","doi-asserted-by":"crossref","unstructured":"2004: Luo D, Li X, Tang S, Song F, Li W, Xie G, Liang J, Zhou J. Epigenetic modifications in neuropathic pain. Molecular Pain. 2021 Nov 26;17:17448069211056767.","DOI":"10.1177\/17448069211056767"},{"key":"10.1016\/j.diabres.2026.113172_b0430","doi-asserted-by":"crossref","unstructured":"2005: Wang W, Cui SS, Lu R, Zhang H. Is there any therapeutic value for the use of histone deacetylase inhibitors for chronic pain?. Brain research bulletin. 2016 Jul 1;125:44-52.","DOI":"10.1016\/j.brainresbull.2016.04.010"},{"issue":"4","key":"10.1016\/j.diabres.2026.113172_b0435","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/glia.24328","article-title":"Histone deacetylase 5\u2010induced deficiency of signal transducer and activator of transcription\u20103 acetylation contributes to spinal astrocytes degeneration in painful diabetic neuropathy","volume":"71","author":"Fan","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.diabres.2026.113172_b0440","doi-asserted-by":"crossref","unstructured":"Saliba A, Du Y, Feng T, Garmire L. Multi-Omics Integration in Nephrology: Advances, Challenges, and Future Directions. InSeminars in nephrology 2025 Apr 11 (p. 151584). WB Saunders.","DOI":"10.1016\/j.semnephrol.2025.151584"},{"issue":"6","key":"10.1016\/j.diabres.2026.113172_b0445","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/cells10061340","article-title":"The emerging role of HDACs: pathology and therapeutic targets in diabetes mellitus","volume":"10","author":"Dewanjee","year":"2021","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.diabres.2026.113172_b0450","article-title":"Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer","volume":"14","author":"Guo","year":"2025","journal-title":"Front Immunol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:47:48Z","timestamp":1780105668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":90,"alternative-id":["S0168822726000914"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113172","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperglycaemia-induced metabolic stress and epigenetic imprinting in the inflammatory pathogenesis of diabetic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113172"}}